0001437749-21-000449.txt : 20210108 0001437749-21-000449.hdr.sgml : 20210108 20210108211737 ACCESSION NUMBER: 0001437749-21-000449 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201219 FILED AS OF DATE: 20210108 DATE AS OF CHANGE: 20210108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pellegrino Joseph P JR CENTRAL INDEX KEY: 0001365733 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 21518910 MAIL ADDRESS: STREET 1: 68 BEACON STREET CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2020-12-19 2020-12-23 0001158895 LEMAITRE VASCULAR INC LMAT 0001365733 Pellegrino Joseph P JR C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 Chief Financial Officer Common Stock 2020-12-19 4 M 0 11 0 A 7360 D Common Stock 2020-12-19 4 F 0 160 37.94 D 7200 D Common Stock 2020-12-20 4 M 0 5 0 A 7205 D Common Stock 2020-12-20 4 F 0 105 37.94 D 7100 D Common Stock 2020-12-22 4 M 0 11 0 A 7111 D Common Stock 2020-12-22 4 F 0 121 37.38 D 6990 D Dividend Equivalent Rights 2020-12-19 4 M 0 11 0 D Common Stock 11 39 D Dividend Equivalent Rights 2020-12-20 4 M 0 5 0 D Common Stock 5 17 D Dividend Equivalent Rights 2020-12-22 4 M 0 11 0 D Common Stock 11 20 D Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. This amendment corrects errors made by the Issuer's stock plan administrator in 1) the number of shares acquired by the Reporting Person upon the release of dividend equivalent rights on 12/22/2020, 2) the number of shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units on 12/22/2020 and 3) the number of dividend equivalent rights released in connection with the vesting of restricted stock units on 12/22/2020, all of which were previously reported on a Form 4. /s/ Laurie A. Churchill, Attorney-in-fact 2021-01-08